First-ever withdrawal drug could vault more patients into MAT

FDA chief: First-ever withdrawal drug could vault more patients into addiction therapy

By Angus Liu

Patients who go off opioid painkillers face excruciating withdrawal symptoms such as anxiety, nausea, vomiting, insomnia, muscle aches and more. Now, thanks to an FDA approval for US WorldMeds' Lucemyra, they'll have the first drug designed to fight those symptoms.

Read article: https://www.fiercepharma.com/pharma/fda-approves-lucemyra-first-med-to-ease-symptoms-opioid-withdrawal